LifestyleMidday Maryland


New Treatment for MS

Posted at 2:40 PM, Nov 03, 2020
and last updated 2020-11-03 14:40:07-05

Multiple Sclerosis (MS) is an inflammatory disease that affects more than 2.3 million people. While each person experiences the disease differently, common symptoms include headaches, fatigue, weakness, and tingling in the body.

Kesimpta is a new FDA approved treatment for relapsing MS. The treatment is monthly and self administered, and can help address some common symptoms.

Learn more here.